what the heck are ttfields and should I even worry about it right now

The STELLAR trial is worth looking up when you're ready, it's the main study Novocure ran for mesothelioma specifically and it showed a median overall survival of 18.2 months with TTFields plus chemotherapy versus 12.1 months with chemo alone. Not a cure, and the trial had limitations, but that's a real signal.

What doesn't get talked about enough is the compliance piece. The device tracks how many hours you actually wear it, and the patients in that trial who wore it more than 18 hours a day consistently did better than those who didn't hit that threshold. So the bulkiness Frank mentioned from Norfolk isn't just a comfort issue, it actually affects whether the thing works.

Given you're Stage I post-EPP and still in chemo, your team is right to table it for now. But worth asking Dr. Patel specifically what your compliance target would look like if you do add it down the road, because going back to work while hitting 18 hours a day is... a real conversation to have before you commit.

Talk to your own oncologist before making any decisions on this, but don't let the device intimidate you before you've even seen the data.

Not a TTFields user myself but I've had clients who were, and I want to share what I've seen from a practical standpoint since this question comes up more than people might expect.

The device you're describing is the Optune Lua system, FDA cleared for pleural mesothelioma back in 2019 based on the STELLAR trial data. That study showed median overall survival around 18 months for patients using it alongside chemo, which compared reasonably well to historical controls. Not a slam dunk, but the numbers were interesting enough that oncologists started paying attention.

From what clients have told me, the wearability thing is real. One guy I worked with said he could manage it okay at home but traveling even to a doctor's appointment became this whole production. Another said after about three weeks it just became background noise in his routine. So it really does seem to depend on the person.

The Stage I piece you mentioned actually matters a lot here. Your team's instinct to let chemo do its work first and hold TTFields in reserve sounds reasonable given where you are right now. That's not a door closing, that's just sequencing.

One thing worth knowing from a legal perspective, some asbestos trust claims and settlement structures may have provisions that account for ongoing treatment costs including devices like this. Whether that applies to your situation depends heavily on your specific exposure history and which trusts are potentially involved. Please consult an attorney familiar with your state's asbestos litigation statutes, because this varies considerably by jurisdiction.

You're only a few months out from EPP. That's still pretty fresh.

Your oncologist gave you a pretty accurate lay explanation honestly. The device is called Optune Lua (the mesothelioma-specific version) and it works by delivering alternating electric fields at a specific frequency, 150 kHz for mesothelioma, that disrupts mitosis (cell division) without the systemic toxicity you get from chemo.

The trial that got people excited was STELLAR, published in 2021. Median overall survival in the TTFields plus chemo arm was around 18.2 months compared to historical controls sitting closer to 12. Not a randomized controlled trial, which is the honest caveat, so the results need to be interpreted carefully. But the signal was strong enough that NCCN added it to guidelines.

The wearability thing is real and I won't pretend otherwise. Patients I've worked with describe it as manageable once they settle into a routine, but the first few weeks are genuinely disruptive. Skin irritation under the electrodes is the most common complaint, around 45% of patients in STELLAR reported it, usually mild to moderate.

Here's the thing though, given you're Stage I post-EPP and still in the chemo phase, your team is thinking about this exactly right. You'd revisit it if the picture changes. Recovery from EPP through February is still pretty fresh. That's a lot to be carrying already.

Definitely keep this conversation going with Dr. Patel as things progress, your oncologist knows your specific pathology and margins and that matters a lot for timing.